KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Imax (IMAX) EBT (2016 - 2025)

Imax (IMAX) has disclosed EBT for 16 consecutive years, with $6.6 million as the latest value for Q4 2025.

  • Quarterly EBT fell 20.66% to $6.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $63.3 million through Dec 2025, up 67.89% year-over-year, with the annual reading at $63.3 million for FY2025, 67.89% up from the prior year.
  • EBT hit $6.6 million in Q4 2025 for Imax, down from $27.8 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $27.8 million in Q3 2025 to a low of -$9.3 million in Q1 2022.
  • Historically, EBT has averaged $7.4 million across 5 years, with a median of $7.5 million in 2024.
  • Biggest five-year swings in EBT: crashed 178.53% in 2022 and later skyrocketed 1269.41% in 2023.
  • Year by year, EBT stood at $24.5 million in 2021, then crashed by 75.14% to $6.1 million in 2022, then plummeted by 76.04% to $1.5 million in 2023, then surged by 469.75% to $8.3 million in 2024, then dropped by 20.66% to $6.6 million in 2025.
  • Business Quant data shows EBT for IMAX at $6.6 million in Q4 2025, $27.8 million in Q3 2025, and $13.4 million in Q2 2025.